In a nutshell This study compared the safety and effectiveness of liraglutide (Victoza) to insulin glargine (Lantus) on glycemic (blood glucose) control in patients with type 2 diabetes (T2D) after hospital discharge. The authors concluded that liraglutide treatment led to improved glycemic control and greater weight loss compared to...
Read MoreRecent HbA1C value-Above 7 Posts on Medivizor
Does weight loss surgery prevent diabetes complications?
In a nutshell This study looked at the effect of bariatric surgery (BS; weight loss surgery) on complications of type 2 diabetes (T2D). It found that patients who had BS had fewer vision, foot, and kidney complications. Some background Diabetes is a long-lasting health condition that involves high levels of sugar in the blood. Over time, high blood...
Read MoreEvaluating henagliflozin in patients with type 2 diabetes
In a nutshell This study tested the ability of henagliflozin (SHR3824) in controlling blood glucose levels in patients with type 2 diabetes (T2D). The authors found that henagliflozin alone was able to control glucose levels, reduce body weight and blood pressure in these patients. Some background Insulin is a hormone produced by the...
Read MoreComparing weight loss surgery methods for T2D remission
In a nutshell This review compared the effects of two types of bariatric surgery (weight loss surgery) on type 2 diabetes (T2D) remission over five years. It found that Roux-en-Y gastric bypass (RYGB) led to better diabetes outcomes than sleeve gastrectomy (SG). It also found that both types of surgery led to improvements in T2D. Some background T2D...
Read MoreWhich diabetic drug is safer for older patients with type 2 diabetes, linagliptin or glimepiride?
In a nutshell This study compared the safety of two medications, linagliptin (Trajenta) and glimepiride (Amaryl). It found that the medications had the same risk of heart attack, stroke, or heart-related death, while linagliptin was associated with a lower risk of hypoglycemia (dangerously low blood glucose level). Some background There...
Read MoreIs dapagliflozin safe and effective as add-on for patients with type 1 diabetes?
In a nutshell This study looked at the safety and effectiveness of adding dapagliflozin (Forxiga) in poorly controlled type 1 diabetes (T1D). It found that patients treated with dapagliflozin had better blood glucose (sugar) control and more weight loss after 12 months than patients treated with placebo. Some background Dapagliflozin belongs...
Read MoreCalorie-counting: Is there a better way of dieting for patients with type 2 diabetes?
In a nutshell This study compared the traditional diabetic diet (TDD) with a low-carbohydrate diet (LCD) for patients with poorly controlled type 2 diabetes (T2D). They found that the LCD resulted in better blood glucose (sugar) control and reduced need for diabetic medications compared to the TDD. Some background The traditional...
Read MoreCould daily insulin injections be replaced by weekly injections in patients with type 2 diabetes?
In a nutshell This study looked at the treatment of type 2 diabetes with either daily or weekly insulin injections. They found that weekly insulin was as safe and effective as daily injections. Some background Glycated hemoglobin (Hba1c) is a measurement of how well a person’s blood sugars are controlled over a 3 month period. This is...
Read MoreLooking for participants to trial the impact of tailored meals and nutrition education for uncontrolled diabetes
In a nutshell This study is evaluating the effect of medically tailored meals and nutrition education via tele-health for patients with uncontrolled type 2 diabetes (T2D). The outcomes include changes in blood glucose control, body weight, and confidence in self-managing care. This study is taking place in Philadelphia, Pennsylvania, United...
Read MoreCan insulin glargine 300 reduce hypoglycemia risk?
In a nutshell This study compared patients with type 2 diabetes (T2D) switching to either insulin glargine 300 (Toujeo) or insulin glargine 100 (Lantus). It found that both types of insulin glargine improved blood glucose control, and insulin glargine 300 had a lower risk of hypoglycemia (dangerously low blood glucose levels) outside of a clinical...
Read MoreIs dulaglutide more effective than insulin glargine for patients with type 2 diabetes?
In a nutshell This article looked at the effectiveness of dulaglutide (Trulicity) compared to insulin glargine (Lantus) for patients with uncontrolled type 2 diabetes (T2D). This study concluded that dulaglutide is more effective for these patients compared to insulin glargine. Some background Metformin is recommended as a first-line treatment for...
Read MoreEvaluating Glyxambi for patients with Type 2 diabetes
In a nutshell This study evaluated empagliflozin (Jardiance) and linagliptin (Tradjenta) for the treatment of Type 2 diabetes (T2D). This study found that combining both drugs (Glyxambi) was more effective at lowering blood glucose levels than either medication alone, with similar side effects. Some background For patients with T2D, the...
Read More